AIM: To compare the risk of developing advanced colorectal neoplasm (ACRN) according to age in Koreans. METHODS: A total of 70428 Koreans from an occupational cohort who underwent a colonoscopy between 2003 and 2012 at Kangbuk Samsung Hospital were retrospectively selected. We evaluated and compared odds ratios (OR) for ACRN between the young-adults (YA < 50 years) and in the older-adults (OA ≥ 50 years). ACRN was defined as an adenoma ≥ 10 mm in diameter, adenoma with any component of villous histology, high-grade dysplasia, or invasive cancer. RESULTS: In the YA group, age (OR = 1.08, 95%CI: 1.06-1.09), male sex (OR = 1.26, 95%CI: 1.02-1.55), current smoking (OR = 1.37, 95%CI: 1.15-1.63), family history of colorectal cancer (OR = 1.46, 95%CI: 1.01-2.10), diabetes mellitus related factors (OR = 1.27, 95%CI: 1.06-1.54), obesity (OR = 1.23, 95%CI: 1.03-1.47), CEA (OR = 1.04, 95%CI: 1.01-1.09) and low-density lipoprotein-cholesterol (OR = 1.01, 95%CI: 1.01-1.02) were related with an increased risk of ACRN. However, age (OR = 1.08, 95%CI: 1.06-1.09), male sex (OR = 2.12, 95%CI: 1.68-2.68), current smoking (OR = 1.38, 95%CI: 1.12-1.71), obesity (OR = 1.34, 95%CI: 1.09-1.65) and CEA (OR = 1.05, 95%CI: 1.01-1.09) also increased the risk of ACRN in the OA group. CONCLUSION: The risks of ACRN differed based on age group. Different colonoscopic screening strategies are appropriate for particular subjects with risk factors for ACRN, even in subjects younger than 50 years.
AIM: To compare the risk of developing advanced colorectal neoplasm (ACRN) according to age in Koreans. METHODS: A total of 70428 Koreans from an occupational cohort who underwent a colonoscopy between 2003 and 2012 at Kangbuk Samsung Hospital were retrospectively selected. We evaluated and compared odds ratios (OR) for ACRN between the young-adults (YA < 50 years) and in the older-adults (OA ≥ 50 years). ACRN was defined as an adenoma ≥ 10 mm in diameter, adenoma with any component of villous histology, high-grade dysplasia, or invasive cancer. RESULTS: In the YA group, age (OR = 1.08, 95%CI: 1.06-1.09), male sex (OR = 1.26, 95%CI: 1.02-1.55), current smoking (OR = 1.37, 95%CI: 1.15-1.63), family history of colorectal cancer (OR = 1.46, 95%CI: 1.01-2.10), diabetes mellitus related factors (OR = 1.27, 95%CI: 1.06-1.54), obesity (OR = 1.23, 95%CI: 1.03-1.47), CEA (OR = 1.04, 95%CI: 1.01-1.09) and low-density lipoprotein-cholesterol (OR = 1.01, 95%CI: 1.01-1.02) were related with an increased risk of ACRN. However, age (OR = 1.08, 95%CI: 1.06-1.09), male sex (OR = 2.12, 95%CI: 1.68-2.68), current smoking (OR = 1.38, 95%CI: 1.12-1.71), obesity (OR = 1.34, 95%CI: 1.09-1.65) and CEA (OR = 1.05, 95%CI: 1.01-1.09) also increased the risk of ACRN in the OA group. CONCLUSION: The risks of ACRN differed based on age group. Different colonoscopic screening strategies are appropriate for particular subjects with risk factors for ACRN, even in subjects younger than 50 years.
Authors: Geoffrey C Kabat; Moonseong Heo; Jean Wactawski-Wende; Catherine Messina; Cynthia A Thomson; Sylvia Wassertheil-Smoller; Thomas E Rohan Journal: Cancer Causes Control Date: 2013-04-02 Impact factor: 2.506
Authors: Gloria Y F Ho; Tao Wang; Marc J Gunter; Howard D Strickler; Mary Cushman; Robert C Kaplan; Sylvia Wassertheil-Smoller; Xiaonan Xue; Swapnil N Rajpathak; Rowan T Chlebowski; Mara Z Vitolins; Philipp E Scherer; Thomas E Rohan Journal: Cancer Res Date: 2012-04-17 Impact factor: 12.701
Authors: Martin C S Wong; Thomas Y T Lam; Kelvin K F Tsoi; Victor C W Chan; Hoyee W Hirai; Jessica Y L Ching; Joseph J Y Sung Journal: Am J Prev Med Date: 2014-05 Impact factor: 5.043
Authors: D J Harriss; G Atkinson; K George; N Tim Cable; T Reilly; N Haboubi; M Zwahlen; M Egger; A G Renehan Journal: Colorectal Dis Date: 2009-01-17 Impact factor: 3.788
Authors: Daniel Restifo; Joni S Williams; Emma Garacci; Rebekah J Walker; Mukoso N Ozieh; Leonard E Egede Journal: J Diabetes Complications Date: 2018-06-18 Impact factor: 2.852
Authors: Po-Hong Liu; Kana Wu; Kimmie Ng; Ann G Zauber; Long H Nguyen; Mingyang Song; Xiaosheng He; Charles S Fuchs; Shuji Ogino; Walter C Willett; Andrew T Chan; Edward L Giovannucci; Yin Cao Journal: JAMA Oncol Date: 2019-01-01 Impact factor: 31.777
Authors: Zhaohui Jin; Jesse G Dixon; Jack M Fiskum; Hiral D Parekh; Frank A Sinicrope; Greg Yothers; Carmen J Allegra; Norman Wolmark; Daniel Haller; Hans-Joachim Schmoll; Aimery de Gramont; Rachel Kerr; Julien Taieb; Eric Van Cutsem; Christopher Tweleves; Michael O'Connell; Leonard B Saltz; Sotaro Sadahiro; Charles D Blanke; Naohiro Tomita; Jean-Francois Seitz; Charles Erlichman; Takayuki Yoshino; Takeharu Yamanaka; Silvia Marsoni; Thierry Andre; Amit Mahipal; Richard M Goldberg; Thomas J George; Qian Shi Journal: J Natl Cancer Inst Date: 2021-08-18 Impact factor: 11.816
Authors: Lorne J Hofseth; James R Hebert; Anindya Chanda; Hexin Chen; Bryan L Love; Maria M Pena; E Angela Murphy; Mathew Sajish; Amit Sheth; Phillip J Buckhaults; Franklin G Berger Journal: Nat Rev Gastroenterol Hepatol Date: 2020-02-21 Impact factor: 46.802
Authors: Alexi N Archambault; Yi Lin; Jihyoun Jeon; Tabitha A Harrison; D Timothy Bishop; Hermann Brenner; Graham Casey; Andrew T Chan; Jenny Chang-Claude; Jane C Figueiredo; Steven Gallinger; Stephen B Gruber; Marc J Gunter; Michael Hoffmeister; Mark A Jenkins; Temitope O Keku; Loïc Le Marchand; Li Li; Victor Moreno; Polly A Newcomb; Rish Pai; Patrick S Parfrey; Gad Rennert; Lori C Sakoda; Robert S Sandler; Martha L Slattery; Mingyang Song; Aung Ko Win; Michael O Woods; Neil Murphy; Peter T Campbell; Yu-Ru Su; Anne Zeleniuch-Jacquotte; Peter S Liang; Mengmeng Du; Li Hsu; Ulrike Peters; Richard B Hayes Journal: JNCI Cancer Spectr Date: 2021-05-20